Genasys Reports Preliminary Q3 Sales Of $7M-$7.5M And Adj. EBITDA Loss Of $3M-$3.3M
Revenue for the quarter was primarily impacted by two factors. The first was supply chain constraints associated with the Common Remotely Operated Weapon Station (CROWS) II Technical Refresh program. This constraint has
Genasys made between $7–$7.5 million in sales last quarter, but lost money on operations because supply chain problems slowed down their weapon system business. When a company struggles to get materials, it's a sign to watch whether things improve next quarter or stay stuck.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.